(XRAY) DENTSPLY SIRONA Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(XRAY) DENTSPLY SIRONA Inc. Complete Analysis Pack
See the Bigger Picture
This DENTSPLY SIRONA Inc. BCG Matrix helps you see how the company’s products or business units are positioned across Stars, Cash Cows, Question Marks, and Dogs, making it useful for strategy, portfolio review, and investment analysis. The page already shows a real preview of the actual report content, so you can review the format and value before buying. Purchase the full version to get the complete ready-to-use analysis instantly.
Stars
Primescan intraoral scanners
Primescan intraoral scanners fit a growing chairside digital workflow, as dentists keep moving away from analog impressions toward faster, cleaner scans. DENTSPLY SIRONA Inc. has said digital dentistry remains a core growth area, and Primescan supports both scanner sales and recurring software use. It also feeds downstream restorative demand, so the installed base keeps compounding value. That growth-plus-recurring mix makes Primescan a Star.
CEREC chairside CAD/CAM system
CEREC is one of dentistry’s best-known chairside CAD/CAM systems, with an installed base of over 50,000 systems worldwide and strong brand pull across practices. Same-day digital restorations still have room to grow, so the platform keeps Star-like growth potential inside DENTSPLY SIRONA Inc.’s portfolio. Its large user base and recurring workflow demand support share gains as digital dentistry expands.
Axeos and Orthophos 3D imaging
Axeos and Orthophos 3D sit in DENTSPLY SIRONA Inc.’s Star quadrant because CBCT use keeps rising in general and specialist dentistry, and the Company’s premium systems still hold strong share in upgrades. In FY2025, the imaging base stayed a key growth engine, backed by scale, service, and replacement demand.
Astra Tech Implant System EV
Astra Tech Implant System EV fits the Star slot because premium implants and guided surgery are growing faster than basic implant dentistry. Its digital workflow, from planning to placement, helps keep clinician loyalty in selected markets. DENTSPLY SIRONA Inc. has positioned Astra Tech in a high-growth niche with strong share potential.
- Premium mix supports faster growth
- Digital workflow boosts stickiness
- Clinician loyalty protects share
- Star profile: high share, high growth
CEREC ecosystem software and milling workflow
CEREC software and milling are a Star for DENTSPLY SIRONA Inc. because they anchor chairside CAD/CAM dentistry, drive service fees, and support consumable pull-through. In the FY2025 digital dentistry cycle, this platform stayed strategic as same-day restorations kept gaining use.
Central to digital workflow
Supports recurring revenue
Boosts consumable demand
Fits a growing market
DENTSPLY’s digital dentistry stars are driving growth
Stars in DENTSPLY SIRONA Inc. are led by Primescan, CEREC, premium imaging, and Astra Tech Implant System EV. These businesses sit in fast-growing digital dentistry niches, with CEREC installed in over 50,000 systems worldwide and FY2025 digital dentistry still a core growth driver.
| Asset | Signal | Key data |
|---|---|---|
| Primescan | High growth | Chairside scan adoption rising |
| CEREC | Scale | 50,000+ systems worldwide |
| Astra Tech EV | Premium share | Guided implant workflow |
What is included in the product
Detailed Word Document
DENTSPLY SIRONA’s BCG Matrix maps dental units by growth and share to guide invest, hold, or divest decisions.
Editable Excel File
Quick BCG snapshot of DENTSPLY SIRONA Inc. to pinpoint growth, cash cows, and weak spots fast.
Reference Sources
Provides a clear source trail to verify DENTSPLY SIRONA Inc. claims quickly and support more confident investment decisions.
Cash Cows
WaveOne Gold endodontic files
WaveOne Gold endodontic files fit Cash Cow status: endodontics is a mature, repeat-buy category, and WaveOne Gold keeps steady use in root canal workflows. DENTSPLY SIRONA Inc. reports endodontic demand as stable rather than fast-growing, which favors harvestable cash flow over expansion.
Strong brand recognition and installed clinician habit support high share, while the broader endodontic market stays low-growth in 2025. That mix of repeat purchasing, routine replenishment, and limited category growth is classic Cash Cow economics for DENTSPLY SIRONA Inc.
ProTaper Ultimate endodontics
ProTaper Ultimate is a long-running canal shaping and preparation franchise, so it fits DENTSPLY SIRONA Inc.'s Cash Cow profile. It serves a stable global endodontics need, where clinicians keep buying replacement files and related consumables. In DENTSPLY SIRONA Inc.'s 2024 annual filing, the company still generated about $3.8 billion in net sales, showing the scale behind mature, repeat-demand products like ProTaper.
AH Plus and root canal sealers
AH Plus fits a Cash Cow: root canal sealers are repeat-buy consumables with low capital needs, and the category is mature but steady. AH Plus benefits from entrenched clinical use and DENTSPLY SIRONA Inc.'s broad distribution, which supports pricing and replenishment. In FY2025, DENTSPLY SIRONA Inc. remained a multi-billion-dollar dental supplier, so this niche can keep generating cash even with slow growth.
Ceram.x and Prime&Bond restorative materials
Ceram.x and Prime&Bond sit in DENTSPLY SIRONA Inc.'s mature direct restorative market, where repeat use drives steady cash flow. These brands benefit from the Company's long sales reach and dentist familiarity, so they tend to defend share rather than chase fast growth. In BCG terms, they fit Cash Cows because demand is recurring and margins are usually stable.
- Repeat purchases support reliable cash generation.
- Mature category, low growth, strong installed base.
- Useful for funding newer product bets.
Treatment centers and powered handpieces
Treatment centers and powered handpieces fit Cash Cow status because DENTSPLY Sirona can keep earning from the installed base through service, replacement, and upgrades. The line is tied to daily chair use, so demand stays steady even if digital platforms grow faster.
In 2024, DENTSPLY Sirona reported net sales of about $3.8 billion, and these legacy hardware products helped support that base. They are not the fastest growers, but their market presence and recurring spend make them reliable cash generators.
- Installed base drives repeat revenue
- Service and parts are recurring
- Stable demand supports Cash Cow status
DENTSPLY SIRONA’s Cash Cows: Steady Sales, Steady Margins
WaveOne Gold, ProTaper Ultimate, AH Plus, and Ceram.x are Cash Cows for DENTSPLY SIRONA Inc.: mature, repeat-buy products in low-growth endodontic and restorative markets. Their value comes from installed clinician use, routine replenishment, and steady margins, not fast expansion. FY2025 still supports this profile, with DENTSPLY SIRONA Inc. remaining a multi-billion-dollar dental supplier.
| Product | Cash Cow driver |
|---|---|
| WaveOne Gold | Repeat file sales |
| AH Plus | Consumable replenishment |
| Ceram.x | Stable restorative demand |
Preview the Actual Deliverable
DENTSPLY SIRONA Inc. Reference Sources
You're previewing the exact DENTSPLY SIRONA Inc. BCG Matrix report you'll receive after purchase. This is the same final document—no watermarks, no demo pages, and no hidden content. Once purchased, the full version is instantly available for download, use, and sharing. It’s a clean, professional file ready for strategy review or presentation.
Dogs
Precious metal dental alloys
Precious metal dental alloys are a mature, shrinking niche for DENTSPLY SIRONA Inc., as dentists keep shifting to zirconia, ceramics, and CAD/CAM workflows. Lower-cost materials and digital restoratives have taken share, so growth is weak and long-term demand is less relevant. In BCG terms, this fits a Dog: low growth, low strategic upside, and likely cash drain.
Porcelain crown and bridge materials
Porcelain crown and bridge materials sit in a slow, commoditized niche, and they keep losing ground to CAD/CAM workflows and newer ceramics. That makes DENTSPLY SIRONA Inc.’s share in this line look weak, with Dog-like economics: low growth, limited pricing power, and shrinking relevance. In DENTSPLY SIRONA Inc.’s 2025/2026 mix, this type of legacy material is less likely to drive profit than digital and restorative systems.
Legacy urology catheters
Legacy urology catheters are a clear Dog for DENTSPLY SIRONA Inc. because they sit outside its core dental business, where 2024 net sales were about $3.8 billion and the strategy stays centered on digital dentistry. Growth is modest, the fit with imaging, CAD/CAM, and implants is weak, and the line adds little synergy. Low priority, low return, and weak strategic overlap keep it in Dog territory.
Commodity prophylaxis pastes and fluoride products
Commodity prophylaxis pastes and fluoride products sit in the Dogs bucket for DENTSPLY SIRONA Inc.: they are low-differentiation consumables in a crowded market, so pricing power is thin and growth is modest. In DENTSPLY SIRONA Inc.'s 2025 filings, the company still faced softer volumes in slower dental consumables lines while premium digital systems held more value. That makes these products useful for cash, but not for strong returns.
- High price pressure, low brand moat
- Limited growth versus digital products
- Best viewed as cash-generating filler
Older analog accessories and low-end hand instruments
Older analog accessories and low-end hand instruments fit Dogs because DENTSPLY SIRONA Inc. is seeing them squeezed by digital systems and premium equipment, which draw higher margins and faster demand. These lines are mature, fragmented, and hard to scale, so share is usually limited and growth stays weak. In BCG terms, they absorb attention but add little expansion.
- Low growth
- Limited share
- Hard to scale
- Facing digital replacement
DENTSPLY’s Legacy Dogs: Cash-Generating but Left Behind
Dogs in DENTSPLY SIRONA Inc. are legacy, low-growth lines like precious metal alloys, porcelain materials, urology catheters, and commodity consumables. They face digital replacement, thin pricing power, and weak strategic fit, so they add cash but little growth. DENTSPLY SIRONA Inc. reported about $3.8 billion in 2024 net sales, with strategy still centered on digital dentistry.
| Dog segment | Why it fits |
|---|---|
| Legacy materials | Low growth, commoditized |
| Older analog items | Replacing with digital |
Question Marks
SureSmile clear aligners
SureSmile clear aligners fit Question Mark territory: the clear aligner market is still growing fast, but DENTSPLY SIRONA Inc. is up against larger rivals like Align Technology, so share is harder to hold. DENTSPLY SIRONA Inc. reported about $3.8 billion in 2025 net sales, but SureSmile remains a smaller, tougher-to-scale bet. If adoption rises, it can turn into a Star; if not, it stays a low-share growth play.
Consumer-direct aligner channel
Consumer-direct aligners still have growth upside, but the channel is risky: heavy marketing spend, weak retention, and tighter FDA oversight can hurt returns. DENTSPLY SIRONA Inc. does not hold a dominant share here, so the business needs fresh investment to scale or discipline to exit, which fits a Question Mark.
Primeprint 3D printing system
Primeprint 3D printing system sits in a fast-growing dental additive manufacturing market, but DENTSPLY SIRONA Inc. has not yet shown the scale or installed base of larger digital manufacturing rivals. That means adoption is still building in labs and practices, so Primeprint can grow fast, but its share remains uncertain. In BCG terms, this is a clear Question Mark: high growth, low proven share.
DS Core cloud workflow platform
DS Core looks like a Question Mark: cloud-connected dentistry is a growing software layer, and DENTSPLY SIRONA is still building the platform, so share is not yet dominant. The company still faces a scale gap versus its core business, which posted about $3.8 billion in annual sales in the latest reported fiscal year.
That makes DS Core strategically important, but not a Cash Cow yet: it needs more users, tighter workflow integration, and stronger recurring software adoption before it can turn into a high-share winner.
- High growth, still low share
- Build-out phase, not mature
- Key for recurring digital revenue
SureSmile VPro vibration device
SureSmile VPro is a classic Question Mark for DENTSPLY SIRONA Inc.: it sits in a smaller, less proven adjunct orthodontic niche, but can still ride the broader aligner-led demand. Its value depends on how much SureSmile aligner growth pulls VPro adoption, because the device remains far below core aligner scale.
That mix of low current scale and clear upside keeps it in the Question Mark bucket, not a Cash Cow. If DENTSPLY SIRONA Inc. can expand attach rates and clinician use, VPro can gain share fast; if not, it stays a niche add-on.
- Small scale, high upside
- Depends on aligner growth
- Needs stronger adoption
DENTSPLY’s Digital Bets: High Growth, Low Share
Question Marks at DENTSPLY SIRONA Inc. are the company’s digital growth bets: SureSmile, DS Core, Primeprint, SureSmile VPro, and consumer-direct aligners. They sit in growing markets, but DENTSPLY SIRONA Inc. has not yet built dominant share, so each needs more spend, adoption, and workflow pull to justify scale.
| Item | Signal |
|---|---|
| 2025 net sales | $3.8 billion |
| Question Mark profile | High growth, low share |
| Core issue | Adoption still building |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.